Global Nuclear Medicine Market Size & Outlook, 2024-2030
Global nuclear medicine market, 2018-2030 (US$M)
Related Markets
Global nuclear medicine market highlights
- The global nuclear medicine market generated a revenue of USD 17,772.0 million in 2024 and is expected to reach USD 34,508.5 million by 2030.
- The market is expected to grow at a CAGR (2025 - 2030) of 10.2% by 2030.
- In terms of segment, diagnostics accounted for a revenue of USD 16,330.0 million in 2024.
- Diagnostics is the most lucrative product segment registering the fastest growth during the forecast period.
- In terms of region, North America was the largest revenue generating market in 2024.
- Country-wise, UAE is expected to register the highest CAGR from 2025 to 2030.
Global data book summary
| Market revenue in 2024 | USD 17,772.0 million |
| Market revenue in 2030 | USD 34,508.5 million |
| Growth rate | 10.2% (CAGR from 2025 to 2030) |
| Largest segment | Diagnostics |
| Fastest growing segment | Diagnostics |
| Historical data covered | 2018 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Diagnostics, Therapeutics |
Other key industry trends
- In terms of revenue, the North America accounted for 42.9% of the global nuclear medicine market in 2024.
- By country, the U.S. is projected to lead the global market in terms of revenue in 2030.
- By country, UAE is the fastest growing regional market and is projected to reach USD 252.3 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Nuclear Medicine Market Scope
Nuclear Medicine Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Global nuclear medicine market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to nuclear medicine market will help companies and investors design strategic landscapes.
Diagnostics was the largest segment with a revenue share of 91.89% in 2024. Horizon Databook has segmented the Global nuclear medicine market based on diagnostics, therapeutics covering the revenue growth of each sub-segment from 2018 to 2030.
Increasing demand for early accurate diagnosis of diseases, coupled with growing demand for enhanced therapies, is expected to fuel the market. According to Globo can the number of new cancer cases is anticipated to reach 28.4 million within the next two decades, with a rise of 47% from 2020, owing to adoption of western lifestyle, high consumption of alcohol, smoking, poor diet choices, and physical inactivity.
In addition, according to the American Cancer Society, in 2021, 281,550 new cases of breast cancer are estimated to be diagnosed, and around 49,290 new cases of Ductal Carcinoma In Situ (DCIS) cases are expected to occur in the U.S. National Cancer Institute Surveillance Epidemiology and End Results (SEER) Database, 38% of women and 43% of men are estimated to develop cancer during their lifetime.
Reasons to subscribe to Global nuclear medicine market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Global nuclear medicine market databook
-
Our clientele includes a mix of nuclear medicine market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of global-level data and insights on the Global nuclear medicine market , including forecasts for subscribers. This global databook contains high-level insights into Global nuclear medicine market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Global nuclear medicine market size, by regions, 2018-2030 (US$M)
Top 10 countries: Nuclear medicine market size, 2024 (US$M)
Global nuclear medicine market share, by end use, 2024 & 2030 (%, US$M)
Nuclear medicine market: Opportunity assessment by country
Global nuclear medicine market, by region, 2024 (US$M)
Related statistics
No records
No related statistics found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
